Caplight Directory>Investors>Boehringer Ingelheim Venture Fund>Boehringer-ingelheim-venture-fund


Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Ingelheim am Rheinboehringer-ingelheim.com

Overview

Boehringer Ingelheim Venture Fund is the corporate venture capital arm of Boehringer Ingelheim that invests in early-stage, groundbreaking biotechnology and digital health companies.

Year Founded

2010

Portfolio Companies

10

Investments

CompanyDateStageLead
TacalyxApr 2026SeedCo-investor
Centauri Therapeutics LimitedFeb 2026Series ACo-investor
ArrePathJun 2025VC RoundLead
HepaRegeniX GmbHApr 2025Series CCo-investor
BrainomixMar 2025Series CLead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersIngelheim am Rhein
Year Founded2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.